Company Announcements

Director Declaration

Source: RNS
RNS Number : 3124K
Funding Circle Holdings PLC
20 December 2022
 

20 December 2022

LEI: 2138003EK6UAINBBUS19

 

Funding Circle Holdings plc (the "Company")

Director Declaration

In accordance with Listing Rule LR 9.6.14(2), the Company announces that Geeta Gopalan, a Non-Executive Director of the Company, will be appointed as a Non-Executive Director to the Board of Dechra Pharmaceuticals PLC with effect from 1 January 2023.

 

END

 

Enquiries:

Funding Circle Investor Relations

Morten Singleton (+44 7736 297 929)

ir@fundingcircle.com

 

Funding Circle Media Relations

Abigail Whittaker (+44 7989 876136)

press@fundingcircle.com

 

Headland Consultancy

Mike Smith / Stephen Malthouse (+44 20 3805 4822)

 

About Funding Circle:

Funding Circle (LSE: FCH) is a lending platform for small business borrowers. Established in the UK in 2010, and now the leading lending platform to SMEs, the Group also has a material and growing presence in the US. Globally, Funding Circle has provided £14.5bn in loans to c.130,000 businesses. For small business borrowers, Funding Circle provides a leading-edge customer experience, delivered through its technology, machine learning, and data science, coupled with a human touch. Its solutions continue to help customers access the funding they need to succeed. For lending investors, Funding Circle provides access to an alternative asset class in an underserved market, and delivers robust and attractive returns.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RDNTMBLTMTBTMMT